The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

House Democrats want to know what the Trump administration plans to do after it rescinded a Biden-era executive order to ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

With prescription drug costs soaring, Illinois lawmakers announced legislation this week reviving efforts to create a ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

In its motion to dismiss, J&J asserted that the plaintiff did “not allege a concrete harm or injury-in-fact” — a claim with ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

With prescription drug costs soaring, Illinois lawmakers announced legislation this week reviving efforts to create a ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...